Mattiucci, Gian Carlo
 Distribuzione geografica
Continente #
NA - Nord America 7.444
EU - Europa 5.459
AS - Asia 4.902
SA - Sud America 919
Continente sconosciuto - Info sul continente non disponibili 241
AF - Africa 138
OC - Oceania 18
Totale 19.121
Nazione #
US - Stati Uniti d'America 7.251
SG - Singapore 2.289
DE - Germania 1.976
CN - Cina 1.094
SE - Svezia 995
BR - Brasile 752
IT - Italia 572
FR - Francia 473
VN - Vietnam 458
UA - Ucraina 337
IN - India 265
GB - Regno Unito 240
IE - Irlanda 225
ID - Indonesia 158
FI - Finlandia 148
RU - Federazione Russa 104
JP - Giappone 103
TR - Turchia 98
CA - Canada 90
PL - Polonia 89
BD - Bangladesh 75
HK - Hong Kong 74
AR - Argentina 67
BE - Belgio 62
IQ - Iraq 57
MX - Messico 50
NL - Olanda 50
CZ - Repubblica Ceca 39
ZA - Sudafrica 36
CI - Costa d'Avorio 34
IR - Iran 31
ES - Italia 28
AT - Austria 27
EC - Ecuador 27
SA - Arabia Saudita 27
PK - Pakistan 23
CO - Colombia 18
AU - Australia 15
MA - Marocco 14
PH - Filippine 14
TN - Tunisia 14
UZ - Uzbekistan 14
JM - Giamaica 13
VE - Venezuela 13
AZ - Azerbaigian 12
CH - Svizzera 12
KR - Corea 12
UY - Uruguay 12
CL - Cile 11
JO - Giordania 11
LT - Lituania 11
KE - Kenya 10
EU - Europa 9
RO - Romania 9
AE - Emirati Arabi Uniti 8
EG - Egitto 8
IL - Israele 8
KZ - Kazakistan 8
NO - Norvegia 8
NP - Nepal 7
PS - Palestinian Territory 7
AL - Albania 6
BO - Bolivia 6
LK - Sri Lanka 6
LU - Lussemburgo 6
NI - Nicaragua 6
PE - Perù 6
PT - Portogallo 6
PY - Paraguay 6
TT - Trinidad e Tobago 6
AM - Armenia 5
DK - Danimarca 5
GR - Grecia 5
OM - Oman 5
RS - Serbia 5
SN - Senegal 5
BG - Bulgaria 4
CR - Costa Rica 4
DO - Repubblica Dominicana 4
ET - Etiopia 4
KG - Kirghizistan 4
KW - Kuwait 4
MY - Malesia 4
NG - Nigeria 4
PA - Panama 4
SK - Slovacchia (Repubblica Slovacca) 4
BY - Bielorussia 3
DZ - Algeria 3
HN - Honduras 3
LB - Libano 3
NZ - Nuova Zelanda 3
TH - Thailandia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AG - Antigua e Barbuda 2
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
BS - Bahamas 2
BZ - Belize 2
GE - Georgia 2
HU - Ungheria 2
Totale 18.860
Città #
Singapore 1.244
Chandler 1.082
Ashburn 726
San Jose 617
Beijing 239
Jacksonville 228
Dublin 224
Ann Arbor 216
New York 216
San Mateo 202
The Dalles 196
Los Angeles 161
Ho Chi Minh City 151
Dearborn 145
Nanjing 137
Jakarta 134
Lauterbourg 132
Wilmington 131
Munich 122
Woodbridge 117
Boston 115
Milan 112
Hanoi 107
Frankfurt am Main 97
Nürnberg 92
Tokyo 91
Marseille 73
Warsaw 72
Hong Kong 70
São Paulo 70
Princeton 69
Bremen 67
Izmir 65
Rome 63
Hefei 62
Brussels 61
Fairfield 60
Hyderabad 60
Cattolica 59
Dallas 59
Houston 57
Lawrence 55
Moscow 52
Helsinki 50
Seattle 49
Buffalo 46
Nanchang 45
Santa Clara 45
Council Bluffs 43
Redwood City 43
Boardman 36
London 35
Abidjan 34
Detroit 34
Zhengzhou 33
Chicago 32
Shenyang 29
Kunming 28
Redmond 28
Brooklyn 27
Jiaxing 27
Leawood 27
Atlanta 26
Da Nang 26
Memphis 26
Paris 26
St Louis 26
Nuremberg 25
Johannesburg 24
Orem 24
Amsterdam 23
Augusta 23
Cambridge 23
Shanghai 23
Norwalk 21
Tianjin 21
Toronto 21
Changsha 20
Turku 20
Pune 19
Belo Horizonte 18
Haiphong 18
Hebei 18
Kent 18
Phoenix 18
Stockholm 18
Curitiba 17
Montreal 17
Ottawa 17
Chennai 16
Düsseldorf 16
Rio de Janeiro 16
Baghdad 15
Guangzhou 15
Mexico City 15
Poplar 15
Brasília 14
Hangzhou 14
Washington 14
Baku 12
Totale 9.537
Nome #
Recurrence in region of spared parotid gland in patient receiving definitive intensity-modulated radiotherapy for nasopharyngeal cancer: A case report 281
EP-1181: Prostheses irradiation in breast cancer: clinical and aesthetic outcomes in retrospective series 269
Intensified adjuvant treatment of prostate carcinoma: feasibility analysis of a phase I/II trial 240
Impact of age and co-morbidities in patients with newly diagnosed glioblastoma: a pooled data analysis of three prospective mono-institutional phase II studies 230
Endoscopy-guided brachytherapy for sinonasal and nasopharyngeal recurrences 227
Automatic delineation for replanning in nasopharynx radiotherapy: what is the agreement among experts to be considered as benchmark? 226
Reducing heart dose during left breast cancer radiotherapy: comparison among 3 radiation techniques 220
Comparison of interstitial brachytherapy and surgery as primary treatments for nasal vestibule carcinomas 219
Effect of whole pelvic radiotherapy for patients with locally advanced prostate cancer treated with radiotherapy and long-term androgen deprivation therapy 202
Patients’ Satisfaction by SmileInTM Totems in Radiotherapy: A Two-Year Mono-Institutional Experience 202
A feasibility study of neo-adjuvant low-dose fractionated radiotherapy with two different concurrent anthracycline-docetaxel schedules in stage IIA/B-IIIA breast cancer 199
The impact of the multidisciplinary tumor board (MDTB) on the management of pancreatic diseases in a tertiary referral center 199
Chemoradiation and brachytherapy in biliary tract carcinoma - Long-term results 198
Radiosurgery or Fractionated Stereotactic Radiotherapy plus Whole-brain Radioherapy in Brain Oligometastases: A Long-term Analysis 196
Intensity-modulated radiotherapy with simultaneous integrated boost to dominant intraprostatic lesion: preliminary report on toxicity 194
Postoperative intensity modulated radiation therapy in high risk prostate cancer: a dosimetric comparison 194
Concurrent and adjuvant temozolomide-based chemoradiotherapy schedules for glioblastoma. Hypotheses based on two prospective phase II trials 193
Clinical validation of atlas-based auto-segmentation of pelvic volumes and normal tissue in rectal tumors using auto-segmentation computed system 193
Chemoradiation and brachytherapy in extrahepatic bile duct carcinoma 191
Intraluminal brachytherapy without stenting in intrahepatic papillary cholangiocarcinoma: a case report 190
Long-term Analysis of Gemcitabine-based Chemoradiation after Surgical Resection for Pancreatic Adenocarcinoma 189
Capecitabine based postoperative accelerated chemoradiation of pancreatic carcinoma. A dose-escalation study. 186
Quality of life and toxicity of stereotactic radiotherapy in pancreatic tumors: a case series 185
Effect of whole pelvic radiotherapy for patients with locally advanced prostate cancer treated with radiotherapy and long-term androgen deprivation therapy 178
Postoperative intensity modulated radiation therapy in high risk prostate cancer: A dosimetric comparison. 177
Long-term analysis of gemcitabine-based chemoradiation after surgical resection for pancreatic adenocarcinoma 177
External beam radiotherapy plus 24 hours continuous infusion of gemcitabine in unresectable pancreatic carcinoma: long term result of a phase II study 175
Reducing heart dose during left breast cancer radiotherapy: Comparison among 3 radiation techniques 173
Stereotactic radiosurgery (SRS) with volumetric modulated arc therapy (VMAT): interim results of a multi-arm phase I trial (DESTROY-2) 172
Intraoperative radiation therapy in resected pancreatic carcinoma: long-term analysis. 171
Adjuvant chemoradiotherapy in gastric cancer: a pooled analysis of the AIRO gastrointestinal group experience 170
Inter-observer variability of clinical target volume delineation in radiotherapy treatment of pancreatic cancer: a multi-institutional contouring experience 168
Postoperative intensity modulated radiation therapy in high risk prostate cancer: a dosimetric comparison 167
Early proctoscopy is a surrogate endpoint of late rectal toxicity in prostate cancer treated with radiotherapy 166
Endoscopy-guided brachytherapy for sinonasal and nasopharyngeal recurrences 165
Postoperative intensity-modulated radiotherapy with simultaneous integrated boost in prostate cancer: A dose-escalation trial 164
Patterns of radiotherapy practice for pancreatic cancer: Results of the Gastrointestinal Radiation Oncology Study Group multi-institutional survey 162
Hypofractionated intensity-modulated radiotherapy with simultaneous integrated boost after radical prostatectomy: preliminary results of a phase II trial 160
Low-dose hyperradiosensitivity: is there a place for future investigation in clinical settings? 159
Functional results of exclusive interventional radiotherapy (brachytherapy) in the treatment of nasal vestibule carcinomas 159
Radiotherapy and concurrent metronomic chemotherapy in hormone-refractory prostate carcinoma: a Phase I study 158
Radioprotective effect of calcium channel blockers against late rectal bleeding in prostate cancer 156
Survival after radiotherapy in gastric cancer: systematic review and meta-analysis. 155
Intensified adjuvant treatment of prostate carcinoma: feasibility analysis of a phase I/II trial 155
PRODIGE: PRediction models in prOstate cancer for personalized meDIcine challenGE 155
Postoperative intensity modulated radiation therapy in high risk prostate cancer: a dosimetric comparison 154
Comparison of interstitial brachytherapy and surgery as primary treatments for nasal vestibule carcinomas 154
Multi-institutional pooled analysis on adjuvant chemoradiation in pancreatic cancer 154
Interventional radiotherapy as exclusive treatment for primary nasal vestibule cancer: Single-institution experience 154
Radiochemotherapy with Gemcitabine in Unresectable Extrahepatic Cholangiocarcinoma: Long-term Results of a Phase II Study 152
Postoperative intensity-modulated radiotherapy with simultaneous integrated boost in prostate cancer: A dose-escalation trial 150
Clinical management of gastroesophageal junction tumors: past and recent evidences for the role of radiotherapy in the multidisciplinary approach 149
New standards for the management of nose vestibule malignancies 148
The impact of radiomics in diagnosis and staging of pancreatic cancer 148
Delta Radiomics Analysis for Local Control Prediction in Pancreatic Cancer Patients Treated Using Magnetic Resonance Guided Radiotherapy 147
Low-dose radiotherapy and concurrent FOLFIRI-bevacizumab: A Phase II study 146
[Radiotherapy in men with prostate cancer: indications, evolutions and integrated approaches] 144
Locally advanced prostate cancer: three-dimensional magnetic resonance spectroscopy to monitor prostate response to therapy 143
EROS study: Evaluation between high-dose-rate and low-dose-rate vaginal interventional radiotherapy (brachytherapy) in terms of overall survival and rate of stenosis 143
RUNX3 as a Potential Predictor of Metastasis in Human Pancreatic Cancer 142
May we routinely spare hippocampal region in primary central nervous system lymphoma during whole brain radiotherapy? 141
A deep learning approach to generate synthetic CT in low field MR-guided radiotherapy for lung cases 141
Correction to: Hypofractionated sequential radiotherapy boost: a promising strategy in inoperable locally advanced pancreatic cancer patients (Journal of Cancer Research and Clinical Oncology, (2021), 147, 3, (661-667), 10.1007/s00432-020-03411-7) 141
Postoperative intensity-modulated radiotherapy with simultaneous integrated boost in prostate cancer: A dose-escalation trial 140
Adjuvant Chemoradiation in Pancreatic Cancer: A Pooled Analysis in Elderly (≥75 years) Patients 140
Modern Management of Esophageal Cancer: Radio-Oncology in Neoadjuvancy, Adjuvancy and Palliation 139
Effect of whole pelvic radiotherapy for patients with locally advanced prostate cancer treated with radiotherapy and long-term androgen deprivation therapy 138
Locally Advanced Prostate Cancer: Three-Dimensional Magnetic Resonance Spectroscopy to Monitor Prostate Response to Therapy 138
A new frontier of image guidance: Organs at risk avoidance with MRI-guided respiratory-gated intensity modulated radiotherapy: Technical note and report of a case 137
Intraluminal Brachytherapy in Unresectable Extrahepatic Biliary Duct Cancer: An Italian Pooled Analysis 134
Automatic segmentation software in locally advanced rectal cancer: READY (REsearch program in Auto Delineation sYstem)-RECTAL 02: prospective study 133
Effect of whole pelvic radiotherapy for patients with locally advanced prostate cancer treated with radiotherapy and long-term androgen deprivation therapy 129
Comparison of interstitial brachytherapy and surgery as primary treatments for nasal vestibule carcinomas 129
Locally advanced prostate cancer: three-dimensional magnetic resonance spectroscopy to monitor prostate response to therapy. 129
Can automation in radiotherapy reduce costs? 127
Radiotherapy in men with prostate cancer: indications, evolutions and integrated approaches 126
Perioperative HDR brachytherapy for reirradiation in head and neck recurrences: Single-institution experience and systematic review 126
Magnetic resonance guided SBRT reirradiation in locally recurrent prostate cancer: a multicentric retrospective analysis 125
An atlas for clinical target volume definition, including elective nodal irradiation in definitive radiotherapy of biliary cancer 123
MITHRA - Multiparametric MR/CT image adapted brachytherapy (MR/CT-IABT) in anal canal cancer: A feasibility study 121
Magnetic Resonance, Vendor-independent, Intensity Histogram Analysis Predicting Pathologic Complete Response After Radiochemotherapy of Rectal Cancer 120
Role of chemoradiation (CRT) in the adjuvant treatment of radically resected pancreatic cancer (PC) patients (pts): a mono-institutional retrospective analysis 120
Use of Indirect Target Gating in Magnetic Resonance-guided Liver Stereotactic Body Radiotherapy: Case Report of an Oligometastatic Patient 120
Basics and frontiers on pancreatic cancer for radiation oncology: Target delineation, SBRT, SIB technique, MRgRT, particle therapy, immunotherapy and clinical guidelines 120
PRODIGE: PRediction models in prOstate cancer for personalized meDIcine challenGE 119
Hypofractionated sequential radiotherapy boost: a promising strategy in inoperable locally advanced pancreatic cancer patients 119
Radiation therapy for prostate cancer: What's the best in 2021 119
Prevalence of HPV Infection and p16INK4a Overexpression in Surgically Treated Laryngeal Squamous Cell Carcinoma 118
Individually optimized stereotactic radiotherapy for pancreatic head tumors: A planning feasibility study 117
Hybrid Tri-Co-60 MRI radiotherapy for locally advanced rectal cancer: An in silico evaluation 117
Hypofractionated stereotactic radiotherapy for oligometastatic patients: developing of a response predictive model 117
A Phase I study of high-dose-rate intraluminal brachytherapy as palliative treatment in extrahepatic biliary tract cancer 116
Role of Chemoradiation in the Adjuvant Treatment of Radically Resected Pancreatic Cancer Patients: A Mono-Institutional Retrospective Analysis 115
Beyond geometrical overlap: a Dosimetrical Evaluation of automated volumes Adaptation (DEA) in head and neck replanning 114
Development of a modelling to correlate site and diameter of brain metastases with hippocampal sparing using volumetric modulated Arc therapy 111
Adjuvant chemoradiation in pancreatic cancer: impact of radiotherapy dose on survival 110
MRI-guided stereotactic radiation therapy for hepatocellular carcinoma: a feasible and safe innovative treatment approach 110
Intra-operative radiotherapy (IORT) in pancreatic cancer: Joint analysis of the ISIORT-Europe experience. 109
Online adaptive magnetic resonance guided radiotherapy for pancreatic cancer: state of the art, pearls and pitfalls 109
Patients’ satisfaction by smileintm totems in radiotherapy: A two-year mono-institutional experience 109
Totale 15.659
Categoria #
all - tutte 77.720
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 77.720


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.140 0 65 16 127 57 41 21 198 55 102 212 246
2022/20232.796 371 389 220 464 161 336 139 240 323 31 92 30
2023/20241.259 45 340 41 161 46 192 55 89 11 38 123 118
2024/20252.533 58 87 176 95 270 83 77 130 394 268 508 387
2025/20266.301 952 175 313 670 1.149 313 1.132 335 457 459 203 143
2026/2027473 213 260 0 0 0 0 0 0 0 0 0 0
Totale 19.121